

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Givosiran iyimithi ekhethekile eyenzelwe ukuvimbela ukuhlaselwa okubuhlungu kubantu abane-acute hepatic porphyria, isimo esingavamile sezakhi zofuzo. Le mithi ejovwayo isebenza ngokugxila embangweni wezinhlaselo ze-porphyria, isiza ukunciphisa ukuthi zenzeka kangaki nokuthi ziba nzima kangakanani.
Uma wena noma othile omkhathalelayo otholakale ene-acute hepatic porphyria, cishe ufuna izimpendulo mayelana nezinketho zokwelapha. I-Givosiran imelela ukuqonda okukhulu ekuphatheni lesi simo esiyinselele, inikeza ithemba lempilo ezinzile futhi enethezekile.
I-Givosiran iyimithi kadokotela eyenzelwe ngqo abantu abadala abane-acute hepatic porphyria. Ingaphansi kohlobo lwemithi ebizwa ngokuthi i-small interfering RNA (siRNA) therapies, esebenza ezingeni lezakhi zofuzo ukunciphisa izimpawu zesifo.
Umuthi uza njengesixazululo esicacile, esingenambala osijova ngaphansi kwesikhumba sakho kanye ngenyanga. Cabanga ngayo njengokwelashwa okuhloswe ngakho okusiza umzimba wakho ukuthi uphathe udaba oluyisisekelo lwezakhi zofuzo olubangela ukuhlaselwa kwakho kwe-porphyria.
I-Givosiran ithengiswa ngaphansi kwegama lomkhiqizo elithi Givlaari futhi imelela ukwelashwa kokuqala okuvunywe yi-FDA okwenzelwe ngqo ukuvimbela ukuhlaselwa kwe-acute porphyria kunokumane ukwelapha ngemuva kokuthi kwenzekile.
I-Givosiran isetshenziselwa ukuvimbela ukuhlaselwa okukhulu kubantu abadala abane-acute hepatic porphyria. Lesi simo esingavamile sezakhi zofuzo sithinta indlela umzimba wakho okhiqiza ngayo i-heme, ingxenye ebalulekile ye-hemoglobin ethwala umoya-mpilo egazini lakho.
Uma une-acute hepatic porphyria, umzimba wakho awukwazi ukucubungula kahle amakhemikhali athile abizwa ngokuthi ama-porphyrins. Lawa ayakha futhi angabangela ukuhlaselwa okungazelelwe, okukhulu okubandakanya ubuhlungu obukhulu besisu, isicanucanu, ukuhlanza, futhi ngezinye izikhathi izimpawu ze-neurological njengobuthakathaka bemisipha noma ukudideka.
Umuthi uvunyelwe ngokukhethekile izinhlobo eziningana ze-acute hepatic porphyria, okuhlanganisa i-acute intermittent porphyria, i-hereditary coproporphyria, i-variegate porphyria, kanye ne-ALAD-deficiency porphyria. Udokotela wakho uzoqinisekisa ukuthi unaluphi uhlobo ngemva kokuhlolwa okukhethekile.
I-Givosiran isebenza ngokunciphisa ukukhiqizwa kweprotein ebizwa nge-ALAS1 esibindini sakho. Le protein isebenza ngokweqile kubantu abane-acute hepatic porphyria futhi inegalelo ekwakhekeni kwezinto ezinobuthi ezibangela ukuhlaselwa.
Umuthi usebenzisa ubuchwepheshe be-RNA interference ukuze "uvale" ukukhiqizwa kwale protein enezinkinga. Ngokwenza kanjalo, kunciphisa ukuqongelela kwama-precursors e-porphyrin anobuthi abangela izimpawu zakho.
Lokhu kuthathwa njengomuthi onamandla aphakathi nendawo obhekana nembangela eyinhloko yesimo sakho kunokumane ufihle izimpawu. Izifundo zomtholampilo zikhombisile ukuthi zinganciphisa amazinga okuhlaselwa ngamaphesenti angama-70% ezigulini eziningi, okwenza kube yithuluzi elinamandla ekuphatheni lesi simo esiyinselele.
I-Givosiran inikezwa njenge-subcutaneous injection, okusho ukuthi ifakwa ngaphansi kwesikhumba, ngokuvamile endaweni yesisu sakho, ethangeni, noma engalweni engenhla. Umhlinzeki wakho wezempilo uzokufundisa ukuthi uyifaka kanjani wena, noma ilungu lomndeni lingafunda ukukusiza.
Umuthi unikezwa kanye ngenyanga, futhi umthamo ubalwa ngokusekelwe esisindweni somzimba wakho. Abantu abaningi bathola cishe ama-2.5 mg ngekhilogramu ngayinye yesisindo somzimba njalo ngenyanga. Udokotela wakho uzoqaphela umthamo wakho oqondile futhi akukhombise ukuthi ukala kanjani kahle.
Awudingi ukuthatha i-givosiran ngokudla, futhi akukho mingcele ethile yokudla. Kodwa-ke, kubalulekile ukugcina umuthi esiqandisini sakho futhi uwuvumele ukuthi ufike ezingeni lokushisa legumbi ngaphambi kokufaka. Ungalokothi unyakazise i-vial, ngoba lokhu kungalimaza umuthi.
Khetha indawo yokujova ehlukile inyanga ngayinye ukuze ugweme ukucasuka. Hlanza indawo ngotshwala ngaphambi kokujova, bese ulahla izinaliti ngokuphepha esitsheni esiqinile.
I-Givosiran ngokuvamile iyindlela yokwelapha yesikhathi eside ozoqhubeka nayo uma nje isiza ekuvikeleni ukuhlaselwa kwakho kwe-porphyria. Abantu abaningi abane-acute hepatic porphyria badinga ukwelashwa okuqhubekayo ukuze bagcine izinzuzo.
Udokotela wakho uzoqapha ukusabela kwakho emuthini ezinyangeni ezimbalwa zokuqala ukuze abone ukuthi usebenza kahle kangakanani. Abanye abantu baqaphela ukwehla kokuhlaselwa ezinyangeni ezimbalwa zokuqala, kanti abanye bangase bathathe isikhathi eside ukubona izinzuzo eziphelele.
Isinqumo sokuqhubeka noma ukuyeka ukwelashwa sincike ekutheni umuthi uwalawula kahle kangakanani amasignali akho, ukuthi ukubekezelela kanjani imiphumela emibi, kanye nesimo sakho sempilo esiphelele. Ungalokothi uyeke ukuthatha i-givosiran ngaphandle kokuxoxa ngayo nomhlinzeki wakho wezempilo kuqala, ngoba lokhu kungaholela ekubuyeleni kokuhlaselwa okuvamile.
Njengayo yonke imithi, i-givosiran ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Ukuqonda ukuthi yini okufanele uyibheke kungakusiza ukuthi uzizwe uqiniseka kakhulu ngokwelashwa kwakho.
Imiphumela emibi evame kakhulu ngokuvamile imnene futhi iyalawuleka. Lokhu kuhlanganisa isicanucanu, esithinta cishe u-27% wabantu abathatha umuthi, kanye nokusabela endaweni yokujova njengobubomvu, ukuvuvukala, noma ukuluma lapho ujova umuthi.
Nansi imiphumela emibi ebikwa kaningi:
Le miphumela emibi evamile ivame ukuthuthuka njengoba umzimba wakho ujwayela umuthi ezinyangeni ezimbalwa zokuqala zokwelashwa.
Imiphumela emibi engathi sína kodwa engavamile ingenzeka, futhi kubalulekile ukuyazi. Abanye abantu bangase babe nezinkinga zezinso, yingakho udokotela wakho ezohlola ukusebenza kwezinso zakho ngokuhlolwa kwegazi njalo.
Imiphumela emibi engavamile kodwa engathi sína ihlanganisa:
Uma uhlangabezana nesicanucanu esikhulu, ukuhlanza, ukukhathala okungavamile, noma yiziphi izimpawu zokungezwani komzimba njengobunzima bokuphefumula noma ukuvuvukala ebusweni bakho noma emqaleni, xhumana nomhlinzeki wakho wezempilo ngokushesha.
I-Givosiran ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungele yini wena. Umuthi uvunyelwe kuphela kubantu abadala, ngakho-ke akunconywa ezinganeni noma entsheni engaphansi kweminyaka engu-18.
Akufanele uthathe i-givosiran uma wazi ukuthi unokungezwani komzimba nomuthi noma yiziphi izingxenye zawo. Udokotela wakho uzobuyekeza uhlu lwezithako nawe uma unomlando wokungezwani komzimba nemithi.
Abantu abanezifo ezinzima zezinso bangase badinge ukuqapha okukhethekile noma ukulungiswa komthamo, njengoba umuthi ungase uthinte ukusebenza kwezinso. Udokotela wakho uzohlola ukusebenza kwezinso zakho ngaphambi kokuqala ukwelashwa futhi njalo ngesikhathi sokwelashwa kwakho.
Abesifazane abakhulelwe nabancelisayo kufanele baxoxe ngezinhlaka nezinzuzo ngokucophelela nomhlinzeki wabo wezempilo. Ngenkathi kukhona idatha elinganiselwe ekusetshenzisweni kwe-givosiran ngesikhathi sokukhulelwa, umuthi unganqunywa uma izinzuzo zidlula izingozi ezingaba khona.
I-Givosiran ithengiswa ngaphansi kwegama lomkhiqizo elithi Givlaari, elenziwa yi-Alnylam Pharmaceuticals. Leli okwamanje yilona kuphela igama lomkhiqizo lapho i-givosiran itholakala khona.
I-Givlaari iza ngamaviyali asetshenziswa kanye aqukethe i-189 mg ye-givosiran ku-1 mL yesixazululo. Umuthi udinga incwadi kadokotela futhi ngokuvamile utholakala ngemithi ekhethekile enolwazi lokusingatha imithi ethintekayo emazingeni okushisa.
Ngenxa yokuthi i-givosiran ingumuthi omusha, izinhlobo ezivamile azikatholakali. Igama lomkhiqizo elithi Givlaari lizoba yilona kuphela ongakhetha ngalo ukuthola lokhu kwelashwa.
Ngaphambi kokuba i-givosiran itholakale, izinketho zokwelapha zokuvimbela ukuhlaselwa kwe-acute porphyria zazinomkhawulo. Indlela enkulu yokunye ihlanganisa ukuphatha izimbangela nokwelapha ukuhlaselwa uma kwenzeka.
Ukuphathwa kwendabuko kuhlanganisa ukugwema izimbangela ezaziwayo njengemithi ethile, ukucindezeleka, ukuzila ukudla, notshwala. Abanye abantu futhi basebenzisa i-hemin (ethengiswa njenge-Panhematin) ukwelapha ukuhlaselwa okukhulu, nakuba lokhu kunikezwa ngomthambo esibhedlela.
Ukuguqulwa kwendlela yokuphila kusebalulekile ngisho nangokwelashwa nge-givosiran. Lokhu kuhlanganisa ukugcina izindlela zokudla ezivamile, ukuphatha ukucindezeleka, ukuhlala unamanzi, nokugwema imithi eyaziwayo.
Abanye abantu bangazuza futhi kumasu okuphatha ubuhlungu, ukusekelwa kokudla okunomsoco, nokwelulekwa ukuze babhekane nemvelo engapheli ye-porphyria. Ithimba lakho lokunakekelwa kwezempilo lingakusiza ukuthi uthuthukise uhlelo oluphelele lokuphatha.
I-Givosiran ne-hemin zisebenzela izinjongo ezihlukene ekwelashweni kwe-porphyria, ngakho ukuqhathanisa ngokuqondile akulula. I-Givosiran yenzelwe ukuvimbela ukuhlaselwa ngaphambi kokuba kwenzeke, kuyilapho i-hemin isetshenziselwa ukwelapha ukuhlaselwa okwenzeka kakade.
I-Hemin (Panhematin) idinga ukulaliswa esibhedlela nokuphathwa ngomthambo, okwenza kungasebenzi ukusetshenziswa njalo kokuvimbela. Ngokuvamile igcinelwe ukwelapha ukuhlaselwa okukhulu okungaphenduli kwezinye izindlela.
I-Givosiran inikeza inzuzo yokuba ukwelashwa okuvikelayo ongaziphatha wena ekhaya kanye ngenyanga. Izifundo zomtholampilo zibonisa ukuthi inganciphisa imvamisa yokuhlasela ngamaphesenti angaba ngu-70%, okungenzeka kuqede isidingo sokwelashwa kwe-hemin njalo.
Abantu abaningi bathola ukuthi i-givosiran ithuthukisa kakhulu izinga lempilo yabo ngokunciphisa kokubili imvamisa nobukhulu bokuhlaselwa. Kodwa-ke, ezinye iziguli zingase zidinge ngezinye izikhathi i-hemin yokuhlaselwa okusha, ngakho ukwelashwa kungasekelana.
I-Givosiran ingathinta ukusebenza kwezinso, ngakho-ke abantu abanezinkinga zezinso ezikhona badinga ukuqashwa ngokucophelela. Udokotela wakho uzohlola ukusebenza kwezinso zakho ngaphambi kokuqala ukwelashwa futhi njalo ngesikhathi sokwelashwa kwakho.
Uma unezifo zezinso ezilula kuya kweziphakathi, ungase ukwazi ukusebenzisa i-givosiran, kodwa udokotela wakho angase alungise umthamo wakho noma akuqaphele eduze. Abantu abanezifo zezinso ezinzima bangase badinge ukucabangela ezinye izindlela zokwelapha noma bamukele ukugadwa kwezokwelapha okuseduze.
Uma ngempela ujova i-givosiran eningi kunaleyo ebekiwe, xhumana nomhlinzeki wakho wezempilo noma isikhungo sokulawula ubuthi ngokushesha. Ngenkathi imininingwane yokweqisa ilinganiselwe ngenxa yokusha komuthi, kubalulekile ukufuna iseluleko sezokwelapha ngokushesha.
Ungazami ukukhokhela ngokweqa umthamo wakho olandelayo noma ukunciphisa imithamo yesikhathi esizayo ngokwakho. Udokotela wakho uzokweluleka ngendlela engcono kakhulu yokwenza futhi angase akufune ukukuqapha eduze ukuze uthole imiphumela emibi.
Uma uphuthelwa umjovo wakho wanyanga zonke we-givosiran, wuthatha ngokushesha lapho ukhumbula, bese uqhubeka nohlelo lwakho lwanyanga zonke olujwayelekile kusukela ngalelo phuzu. Ungaphindi imithamo ukuze ulungise umjovo ophuthelwe.
Uma ungaqinisekile ngesikhathi noma uphuthelwe imithamo eminingi, xhumana nomhlinzeki wakho wezempilo ukuze uthole isiqondiso. Bangakusiza ukuthi ubuyele emgqeni ngohlelo lwakho lokwelashwa ngokuphepha.
Akufanele uyeke ukuthatha i-givosiran ngaphandle kokuxoxa ngayo kuqala nomhlinzeki wakho wezempilo. Ukuyeka umuthi cishe kuzoholela ekubuyeleni kokuhlaselwa kwe-porphyria njalo, njengoba isimo esingaphansi singelashwanga.
Udokotela wakho angase acabange ukuyeka ukwelashwa uma uhlangabezana nemiphumela emibi engaphezu kwezinzuzo, noma uma isimo sakho sishintsha kakhulu. Noma yisiphi isinqumo sokuyeka kufanele senziwe kanye nethimba lakho lezempilo.
Yebo, ungahamba nge-givosiran, kodwa kudinga ukuhlela okuthile njengoba umuthi udinga ukuqandiswa. Letha incwadi evela kudokotela wakho echaza isidingo sakho sezokwelapha somuthi ojovwayo uma uhamba ngomoya.
Sebenzisa icala lokuhamba elinokuvikela elinamaphakethe eqhwa ukuze ugcine umuthi ubanda ngesikhathi sokuthutha. Vumela isikhathi esengeziwe ekuvikelekeni kwesikhumulo sezindiza, njengoba imithi ewuketshezi ingase idinge ukuhlolwa okwengeziwe. Cabangela ukuletha umthamo owengeziwe uma kwenzeka ukubambezeleka kohambo.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.